ELEVATED PLASMA ADRENOMEDULLIN LEVEL IN HYPERTHYROIDISM

Citation
M. Taniyama et al., ELEVATED PLASMA ADRENOMEDULLIN LEVEL IN HYPERTHYROIDISM, European journal of clinical investigation, 26(6), 1996, pp. 454-456
Citations number
16
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
ISSN journal
00142972
Volume
26
Issue
6
Year of publication
1996
Pages
454 - 456
Database
ISI
SICI code
0014-2972(1996)26:6<454:EPALIH>2.0.ZU;2-K
Abstract
Adrenomedullin is a recently discovered peptide that was first purifie d from phaeochromocytoma tissue and has marked vasodilatory activity, causing hypotension. In thyrotoxicosis, various haemodynamic changes a re observed, including an increase in cardiac output and heart rate wi th a concomitant decrease in peripheral vascular resistance. To evalua te the mechanism underlying these haemodynamic changes in thyrotoxicos is, we measured the plasma adrenomedullin concentration in thyrotoxic patients with Graves' disease. The plasma concentration of adrenomedul lin was elevated in hyperthyroid patients (14.7 +/- 5.7 pmol L(-1)) co mpared with euthyroid control subjects (5.6 +/- 1.3 pmol L(-1)) (P < 0 .001). The correlation between the plasma adrenomedullin concentration and serum free thyroid hormone levels was marginally significant. The mean blood pressure was relatively low in the face of an elevated pla sma adrenomedullin level. Adrenomedullin may therefore be responsible for the vasodilatation observed in thyrotoxicosis.